Igor Uppal

PHD Doctor of Philosophy,  Toronto General - University Health Network 

Location: India

Consulting Services

Biostatistics Scientific Writing Admin and Customer Support Grant Submission

Areas Of Interest

Mucopolysaccharidosis VIIs Carotid Artery Injuries Plumbism, Nervous System S 640 P Inherited Olivopontocerebellar Atrophies Vincristin medac Cancers, Adrenocortical Disproportion, Cephalopelvic Exsanguinating Hemorrhages Microscopies, Acoustic Sphincterotomy, Endoscopic Transections, Olfactory Nerve Mastectomies, Simple Blastocyst Implantation Hypofractionation, Radiotherapy Dose Tillmans' Reagent Axolotl T-Lymphocyte, Inducer Iron Oxide (Saccharated) Experimental Error Waardenburg Syndrome, Type 3 Post-Choledochostomy Syndromes Education, Dental, Continuing Aversive Agents Short-Wave Therapy Glucose 6 Phosphatase Deficiency Pneumonolysis Allethrins Assay, Chemiluminescent Nominal Dysphasias beta Cell, Artificial White Dot Syndrome Anti Hepatitis B Antigens Leukocyte Migration Inhibitory Factors Isothiuronium Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride Naftidrofuryl Injury, Brain Component 3, Complement

Professional Narrative

Dr. Igor Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2008
Medical Writer, Harvard Med 2000

Education

Doctor of medicine, Yale School of Medicine 2012
Doctor of osteopathic medicine, Perelman School of Medicine 2000

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :